Catching Up with the RARE Daily: Yondelis, Novartis & KCNQ2

December 12, 2014

We catch you up on all the going ons in the world of rare disease. This week we report on Novartis’s ongoing campaign for Acromegly awareness, the alliance of KCNQ2 and a new soft tissue sarcoma drug called Yondelis.

Stay Connected

Sign up for updates straight to your inbox.